| Literature DB >> 34976674 |
Liying Li1, Ziqiong Wang1, Muxin Zhang1,2, Haiyan Ruan1,3, Linxia Zhou1,3, Xin Wei1,4, Ye Zhu1, Jiafu Wei1, Sen He1.
Abstract
The prevalence of diabetes is increasing rapidly and becoming a major public health issue worldwide. We aimed to develop a novel nomogram model for long-term diabetic risk prediction in a Chinese population. A prospective cohort study was performed on 687 nondiabetic individuals who underwent routine physical examination in 1992 and 2007. Using the least absolute shrinkage and selection operator model to optimize feature selection. Multiple Cox regression analysis was performed, and a simple nomogram was constructed. The area under receiver operating characteristic curve (AUC) and calibration plot were conducted to assess the predictive accuracy of the model. The model was subjected to bootstrap internal validation. Of the 687 participants without diabetes at baseline, 74 developed diabetes during the follow-up time. This simple nomogram model was constructed by family history of diabetes, height, waist circumference, triglycerides, fasting plasma glucose and white blood cell count. The AUCs were 0.812 (95% CI: 0.729-0.895) and 0.794 (95% CI: 0.734-0.854) for 10-year and 15-year diabetic risk. The bootstrap corrected c-index was 0.771 (95% CI: 0.721-0.821). The calibration plot also achieved good agreement between observational and actual diabetic incidence. The stratification into different risk groups by optimal cut-off value of 12.8 allowed significant distinction between cumulative diabetic incidence curves in the whole cohort and several subgroups. We established and internally validated a novel nomogram which can provide individual diabetic risk prediction for Chinese population and this practical screening model may help clinicians to identify individuals at high risk of diabetes.Entities:
Keywords: Chinese population; Diabetes; Nomogram; Prediction; Risk score model
Year: 2021 PMID: 34976674 PMCID: PMC8684021 DOI: 10.1016/j.pmedr.2021.101618
Source DB: PubMed Journal: Prev Med Rep ISSN: 2211-3355
Baseline characteristics.
| Variable | All | Subsequent non-diabetic subjects (n = 613) | Subsequent diabetic subjects (n = 74) | p value |
|---|---|---|---|---|
| Age (years) | 48.0 (44.0–53.0) | 48.0 (44.0–53.0) | 51.0 (46.0–54.0) | 0.009 |
| Male sex | 399 (58.1%) | 351 (57.3%) | 48 (64.9%) | 0.259 |
| Smoking | 248 (36.1%) | 216 (35.2%) | 32 (43.2%) | 0.220 |
| Alcohol intake | 87 (12.7%) | 75 (12.2%) | 12 (16.2%) | 0.431 |
| Exercise | 146 (21.3%) | 132 (21.5%) | 14 (18.9%) | 0.712 |
| Hypertension | 104 (15.1%) | 88 (14.4%) | 16 (21.6%) | 0.140 |
| Height (cm) | 161 (155–167) | 161 (155–167) | 160 (154–168) | 0.800 |
| Weight (kg) | 60.0 (54.0–66.0) | 60.0 (54.0–66.0) | 65.0 (56.2–72.0) | <0.001 |
| Waist (cm) | 76.0 (71.0–82.0) | 75.0 (70.0–81.0) | 80.5 (76.0–87.0) | <0.001 |
| Hip (cm) | 92.0 (88.0–96.0) | 92.0 (88.0–95.0) | 95.0 (90.2–97.8) | 0.001 |
| BMI (kg/m2) | 23.2 (21.4–25.1) | 23.1 (21.2–24.9) | 24.8 (22.9–27.0) | <0.001 |
| WHR | 0.83 (0.78–0.87) | 0.82 (0.78–0.87) | 0.86 (0.83–0.89) | <0.001 |
| SBP (mmHg) | 110 (104–120) | 110 (104–120) | 120 (107–129) | 0.021 |
| DBP (mmHg) | 72.0 (70.0–80.0) | 72.0 (70.0–80.0) | 74.0 (70.0–80.0) | 0.095 |
| FPG (mmol/L) | 4.22 (3.78–4.72) | 4.00 (3.78–4.72) | 4.50 (4.00–5.17) | <0.001 |
| TC (mmol/L) | 4.44 (3.97–4.99) | 4.29 (3.93–4.99) | 4.44 (4.27–4.99) | 0.023 |
| TG (mmol/L) | 1.86 (1.51–2.39) | 1.82 (1.51–2.30) | 2.39 (1.73–3.09) | <0.001 |
| LDL-C (mmol/L) | 2.22 (1.73–2.74) | 2.20 (1.73–2.73) | 2.41 (1.64–2.87) | 0.387 |
| HDL-C (mmol/L) | 1.19 (1.06–1.37) | 1.24 (1.06–1.37) | 1.16 (0.98–1.36) | 0.007 |
| WBCC (×109/L) | 5.50 (4.90–6.60) | 5.50 (4.80–6.50) | 5.80 (5.10–6.77) | 0.051 |
| Fibrinogen (g/dL) | 0.41 (0.34–0.45) | 0.41 (0.34–0.45) | 0.41 (0.32–0.46) | 0.579 |
| Hematocrit (%) | 44.0 (40.5–47.0) | 44.0 (40.2–47.0) | 45.0 (41.1–47.4) | 0.068 |
| Plasma viscosity (cP) | 2.05 (1.91–2.44) | 2.05 (1.91–2.49) | 2.04 (1.91–2.27) | 0.607 |
| Family history of diabetes | 26 (3.78%) | 20 (3.26%) | 6 (8.11%) | 0.051 |
Data are presented as median with inter-quartile range, or number (percentage).Abbreviations: BMI = body mass index, WHR = waist to hip ratio, SBP = systolic blood pressure, DBP = diastolic blood pressure, FPG = fasting plasma glucose, TC = total cholesterol, TG = triglyceride, LDL-C = low-density lipoprotein cholesterol, HDL-C = high-density lipoprotein cholesterol, WBCC = white blood cell count.
Variables included in the final diabetic risk model.
| Variable | Beta coefficient | Change | HR (95% CI) | p value |
|---|---|---|---|---|
| Family history of diabetes | 0.969 | yes vs. no | 2.64 (1.14–6.09) | 0.023 |
| Height (cm) | −0.050 | per 1-cm increase | 0.95 (0.92–0.98) | 0.004 |
| WC (cm) | 0.106 | per 1-cm increase | 1.11 (1.08–1.15) | <0.001 |
| TG (mmol/L) | 0.189 | per 1-mmol/L increase | 1.21 (1.04–1.41) | 0.016 |
| FPG (mmol/L) | 0.633 | per 1-mmol/L increase | 1.88 (1.40–2.53) | 0.000 |
| WBCC (×109/L) | 0.357 | per 109/L increase | 1.43 (1.16–1.76) | 0.001 |
HR = hazard ratio; CI = confidence interval
Other abbreviations as in Table 1.
Fig. 1Nomogram to predict the 10-year and 15-year risk of diabetes for the present study cohort. Abbreviations as in Table 1.
Fig. 2The time-dependent ROC curves and calibration plots of the nomogram for 10-year and 15-year diabetic risk prediction. A: ROC curve, B: calibration plot. Abbreviations: AUC = area under the receiver operating curve; DM = diabetes mellitus.
Fig. 3Risk group stratification for the whole study cohort by optimal cut-off value. DM = diabetes mellitus.
Fig. 4Risk group stratification for several subgroups by optimal cut-off value. DM = diabetes mellitus.